DSM leads fragmented nutraceutical ingredients market

The nutraceutical ingredients market remains moderately fragmented, with Koninklijke DSM NV holding the largest share in 2024 and the top 10 players accounting for 20% of revenue. The report points to flavor modulation, plant-based formulations and bioavailability technologies as the main competitive battlegrounds through 2035.

Why it matters: - The nutraceutical ingredients market sits at the center of preventive health, personalized nutrition and functional foods. - Moderate fragmentation leaves room for scale players and specialized suppliers to win share through innovation, compliance and distribution. - Demand for plant-based, clean-label and better-tasting ingredients is shaping product development across supplements, beverages and bars.

What happened: - The Business Research Company published its Nutraceutical Ingredients Global Market Report 2026, covering market size, trends and forecasts for 2026-2035. - Koninklijke DSM NV led global sales in 2024 with a 4% market share. - The top 10 players held 20% of total market revenue in 2024. - Leading companies named in the report include Cargill Incorporated, BASF SE, Archer-Daniels-Midland Company, Lonza Group AG, Kerry Group plc, Tate & Lyle plc, Evonik Industries AG, Roquette Freres SA and Ingredion Incorporated.

The details: - DSM’s nutrition and health business supplies vitamins, carotenoids, omega-3 solutions, nutritional lipids and specialty ingredients. - The report says the market is moderately fragmented because of formulation and compliance barriers, evolving nutritional science, efficacy validation requirements, clean-label expectations and the need for advanced production and sourcing capabilities. - Other major players listed include Merck KGaA, Glanbia plc, Abbott Laboratories, Associated British Foods plc, Ajinomoto Co. Inc., Balchem Corporation, Corbion N.V., Kemin Industries Inc., Novozymes A/S, Arla Foods Amba, Aker Biomarine ASA, FMC Corporation, Sabinsa Corporation, Nutraceutix Inc. and Fonterra Co-operative Group Limited. - Major raw material suppliers listed include Archer-Daniels-Midland Company, Cargill Incorporated, BASF SE, Evonik Industries AG, Roquette Freres SA, Ingredion Incorporated, Corbion N.V., Kemin Industries Inc., Novonesis, Ajinomoto Co. Inc., FMC Corporation, Balchem Corporation, Aker Biomarine ASA, Fonterra Co-operative Group Limited, Arla Foods Amba, Givaudan SA, International Flavors & Fragrances Inc., Südzucker AG, Gelita AG and Lonza Group AG. - Major wholesalers and distributors listed include Brenntag SE, IMCD N.V., Azelis Group NV, Univar Solutions Inc., Barentz International BV, DKSH Holding Ltd., Prinova Group LLC, Nexeo Solutions LLC, Caldic B.V., Biesterfeld AG, ConnOils LLC, Batory Foods Inc., Gillco Ingredients Inc., Foodchem International Corporation, Farbest Brands, Lipoid GmbH, AIDP Inc., Ingredi Corporation, Glanbia Nutritionals and Stauber Performance Ingredients. - Major end users listed include Abbott Laboratories, Nestlé Health Science, Herbalife Ltd., Amway Corporation, PepsiCo Inc., The Coca-Cola Company, Danone S.A., Yakult Honsha Co. Ltd., Haleon plc, Otsuka Holdings Co. Ltd., Mondelez International Inc., General Mills Inc., USANA Health Sciences Inc., Jamieson Wellness Inc., Pfizer Inc., Bayer AG, Mars Inc., Sanofi Consumer Healthcare, Procter & Gamble Company and Reckitt Benckiser Group plc. - The report includes a free sample request and a detailed market report link: More information and the full report.

Between the lines: - Flavor modulation is emerging as a key differentiator because taste can limit adoption of high-protein and plant-based nutrition products. - In July 2025, DSM-Firmenich launched ModulaSENSE maskers for Vertis CanolaPRO, using receptor-based flavor technology for ready-to-mix nutritional beverages and protein bars. - The technology is designed to mask bitterness, optimize taste at the molecular level and improve compatibility with high-protein plant-based formulations. - The report also highlights personalized nutrition, plant-based functional ingredients, bioavailability enhancement, strategic investment and microbiome-focused ingredients as major company strategies.

What's next: - The competitive edge is likely to shift toward companies that can combine efficacy, sensory appeal and clean-label positioning. - Product innovation, strategic collaborations and manufacturing capacity expansion are expected to strengthen leading companies' positions. - The report says future analysis will emphasize market attractiveness scoring, TAM analysis, company scoring matrices, forecasting dashboards, market hotspots and future trend graphics.

The bottom line: - Nutraceutical ingredients is a crowded but still open market, and the next winners will be those that prove health benefits while improving taste, absorption and formulation flexibility.